Cost-effective universal screening for hepatitis C in France

July 4, 2018, Elsevier
Cost-effectiveness analysis for the scenario considering treatment for all. Percentage of acceptability for each strategy by WTP (willingness to pay) threshold. Credit: Elsevier

An estimated 75,000 people in France are unaware they are infected by hepatitis C virus. An ANRS-funded study by Sylvie Deuffic-Burban, Ph.D., a research associate at IAME (Infection, Antimicrobials, Modeling, Evolution) (Inserm—Université Paris Diderot—Université Paris 13), and her team show that a universal screening strategy applied to hepatitis C is cost-effective and improves life expectancy in those infected, compared with targeted screening. These modeling results are published in the Journal of Hepatology.

It is currently recommended in Europe that screening for hepatitis C virus (HCV) should target people at high risk of infection. In France, suggest that in 2014 approximately 75,000 people aged 18 to 80 were infected by HCV but were unaware of their status. In at least one in ten cases, these people are at an advanced stage of the disease when diagnosed. Today's treatments of HCV infection are both highly effective and well-tolerated and cure the infection in a few weeks in over 95 percent of cases. In Professor Yazdan Yazdanpanah's Inserm research team, Dr. Deuffic-Burban has developed a mathematical model that assesses the efficacy and cost-effectiveness of different screening strategies, including .

This study applied data from a 2004 InVS seroprevalence survey to 18- to 80-year-olds in France, excluding people with diagnosed chronic HCV infection. The researchers developed their analytical model using a combination of these seroprevalence data and findings from studies of the characteristics of people infected (age, sex, stage of the disease at diagnosis, alcohol intake, etc.), the natural progression of the disease, the efficacy of treatments, the quality of life of the patients treated, and the cost of treatment of infection. The screening strategies assessed targeted the following groups: the at-risk population only; all men aged between 18 and 59; all people aged between 40 and 59; all people aged between 40 and 80; and everyone aged between 18 and 80 (universal screening).

The modeling results show that universal screening is associated with better adjusted for quality of life than other strategies. Universal screening is cost-effective if the patients tested for HCV infection are treated rapidly after diagnosis.

Dr. Deuffic-Burban points out that "screening, on an individual basis, enables rapid treatment, which avoids the development of serious complications. In time, collective screening helps eliminate hepatitis C from a population that has been screened without restrictions." The results of this ANRS-funded study therefore argue in favor of universal screening for HCV in France, followed by immediate treatment of those diagnosed with HCV infection. Dr. Deuffic-Burban concludes that "although our model is unable to test the idea, the epidemiological similarities of HCV, HIV, and HBV suggest that universal and combined for these three viruses could be of particular interest."

Explore further: Electronic health record alert improves HCV screening and treatment among baby boomers

More information: Sylvie Deuffic-Burban et al. Assessing the cost-effectiveness of hepatitis C screening strategies in France, Journal of Hepatology (2018). DOI: 10.1016/j.jhep.2018.05.027

Related Stories

Electronic health record alert improves HCV screening and treatment among baby boomers

September 15, 2017
In a recent study, screening rates for hepatitis C virus (HCV) infection among baby boomers increased fivefold in the year following implementation of an electronic health record (EHR)-based prompt for primary care physicians. ...

Is newborn screening for congenital cytomegalovirus infection cost effective?

October 10, 2016
Congenital cytomegalovirus (cCMV) infection is a leading cause of childhood hearing loss, cognitive deficits and visual impairments. Estimates suggest 20,000 babies are born with cCMV infection annually in the United States. ...

Screening for hepatocellular carcinoma likely to be cost effective

April 12, 2018
Surveillance for hepatocellular carcinoma (HCC) by ultrasound is likely to be cost effective in patients with hepatitis C-related liver cirrhosis after they have achieved a sustained virological response (SVR) to direct-acting ...

Hepatitis C: A novel point-of-care assay

April 10, 2018
One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus (HCV) is the diagnosis of chronic cases that are generally asymptomatic. Major progress is required for new diagnostic techniques ...

Universal group B streptococci screening not cost-effective

December 13, 2016
(HealthDay)—For women with a singleton pregnancy planning a repeat cesarean delivery, universal group B streptococci (GBS) screening is not cost-effective, according to a study published in the January issue of Obstetrics ...

Study shows universal vaccination has wiped out hepatitis B and associated liver cancer in Alaska's young people

August 10, 2017
Updated research presented at this year's World Indigenous Peoples' Conference on Viral Hepatitis in Anchorage, Alaska, USA (8-9 August) shows that the universal hepatitis B vaccination programme introduced for all newborn ...

Recommended for you

Alcohol-related cirrhosis deaths skyrocket in young adults

July 18, 2018
Deaths from cirrhosis rose in all but one state between 1999-2016, with increases seen most often among young adults, a new study shows.

Childhood abuse linked to greater risk of endometriosis, study finds

July 17, 2018
Endometriosis, a painful condition that affects one in 10 reproductive-age women in the U.S., has been linked to childhood physical and sexual abuse, according to findings published today in the journal Human Reproduction.

Why men might recover from flu faster than women

July 17, 2018
Men may recover more quickly from influenza infections because they produce more of a key lung-healing protein, a study from scientists at Johns Hopkins Bloomberg School of Public Health suggests.

Hidden blood in feces may signal deadly conditions

July 17, 2018
(HealthDay)—Even if it's not visible to the naked eye, blood in the stool can be serious—a sign of a potentially fatal disease other than colon cancer, new research suggests.

Broadly acting antibodies found in plasma of Ebola survivors

July 17, 2018
Recent Ebola virus disease (EVD) outbreaks, including the 2013-2016 epidemic that ravaged West Africa and the 2018 outbreak in the Democratic Republic of the Congo, highlight the need for licensed treatments for this often-deadly ...

Scientists a step closer to predicting epidemics

July 13, 2018
Ecologists at the University of Georgia have taken an important step in their efforts to develop an early warning system for infectious disease outbreaks.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.